Shreeji Pharma Equipment Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 4 Year, 3 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth %
- Profit Growth 686.28%
- Ebitda 1596.83%
- Net Worth 180.50%
- Total Assets 4778.11%
About Shreeji Pharma Equipment
Shreeji Pharma Equipment Private Limited (SPEPL) is a Private Limited Indian Non-Government Company incorporated in India on 27 October 2020 (Four years and three months 5 days old ). Its registered office is in Ahmedabad, Gujarat, India.
The Corporate was formerly known as Shreeji Pharma Equipment Priavate Limited. The Company is engaged in the Machinery And Equipment Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Kirit Gajera and Manishkumar Patel serve as directors at the Company.
Company Details
-
Location
Ahmedabad, Gujarat, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U29100GJ2020PTC117735
-
Company No.
117735
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
27 Oct 2020
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Ahmedabad
Industry
Who are the key members and board of directors at Shreeji Pharma Equipment?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Kirit Gajera
|
Director | 27-Oct-2020 | Current |
|
Manishkumar Patel
|
Director | 27-Oct-2020 | Current |
Financial Performance of Shreeji Pharma Equipment.
Shreeji Pharma Equipment Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 686.28% increase in profit. The company's net worth Soared by an impressive increase of 180.5%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Shreeji Pharma Equipment?
Unlock access to Shreeji Pharma Equipment's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Shreeji Pharma Equipment?
Shreeji Pharma Equipment has a workforce of 0 employees as of Mar 30, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Shreeji Pharma Equipment, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Shreeji Pharma Equipment's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.